Program to help youths at high risk for psychosis in Sacramento
Official title: Increasing Access to Evidence-Based CHR-P Assessment and Treatment Via Stepped-Care in Community-based Settings
Run by University of California, Davis · NCT06640803 · Data updated 2026-11-12
This study is testing a new program to help young people in Sacramento who are at risk for psychosis by providing them with better support and treatment options in local mental health clinics.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 25 Years |
| Sex | All |
| Enrollment | 223 (estimated) |
| Sponsor | University of California, Davis Academic / other |
| Locations | 6 sites (Elk Grove, California and 5 other locations) |
| Status | Recruiting |
| Started | March 20, 2023 |
| Main results expected | October 1, 2026 |
| Study ends | October 1, 2026 |
| Registry record updated | December 15, 2025 |
| Trial ID | NCT06640803 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this program are youths aged 12-25 who are receiving care in designated community mental health clinics and are assessed to be at clinical high risk for psychosis.
✕Probably not a fit
Patients with intellectual disabilities or those requiring urgent clinical care at a higher level will not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This program evaluates a stepped-care intervention aimed at identifying and treating youths aged 12-25 who are at clinical high risk for psychosis in Sacramento, California. It involves universal screening in community mental health clinics and a team-based intervention that includes training in Cognitive Behavioral Case Management (CBCM). The initiative is designed to enhance the capacity of local clinics to manage these at-risk youths and triage them to specialized services when necessary. The program will be implemented across multiple community mental health centers, ensuring access for those with public insurance or no insurance.
Why it matters
Potential benefit: If successful, this program could significantly improve early identification and treatment of psychosis in at-risk youths, potentially preventing the onset of full-blown psychotic disorders.
How similar studies have gone: Other studies have shown success with stepped-care approaches in mental health, indicating potential for this program's effectiveness.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Clinical High Risk for Psychosis Syndrome as assessed by the mini-SIPS 2. Aged between 12-25 years old 3. Receiving care in one of six identified community mental health clinics 4. Eligibility for Sacramento County Medicare 5. Ability to provide informed consent Exclusion Criteria: 1. Intellectual disability (IQ\<70) 2. Urgent clinical need for a higher level of care
Where it's running
-
River Oak Center for Children
Elk Grove, California, United States Recruiting -
Turning Point Community Programs
Elk Grove, California, United States Recruiting -
University of California Department of Psychiatry and Behavioral Sciences; Early Psychosis Programs
Sacramento, California, United States Recruiting -
University of California-Davis CAARE Diagnostic and Treatment Center
Sacramento, California, United States Recruiting -
Capital Star Community Services
Sacramento, California, United States Recruiting -
Heartland Child and Family Services
Sacramento, California, United States Recruiting
Study contacts
- Study coordinator: Daniel I Shapiro, PhD
- Email: dishapiro@ucdavis.edu
- Phone: 916-734-7875
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Accelerated Brain Stimulation for Young People at Risk of Psychosis
This study tests a five-day accelerated brain-stimulation treatment to see if it is safe and tolerable for young people at risk for psychosis and to explore biomarkers that might show whether it works.
-
Recovery-oriented suicide prevention for young people at clinical high risk for psychosis
This program tests a peer-supported, clinician-led suicide prevention group for young people at clinical high risk for psychosis to see if it helps reduce suicidal thoughts and support recovery.
-
Mindfulness group experiences for young people at high risk for or early in psychosis
This project tries to understand how group mindfulness sessions feel for French-speaking young people aged 15–30 who are at ultra‑high risk for psychosis or have had a first episode.
-
Biomarker changes after MT1988 dosing in young people at high risk for psychosis
This will test whether two doses of MT1988 taken twice daily for 8 weeks change biomarker tests in 17–30-year-olds at high risk for psychosis compared with placebo.
-
Digital DBT for Youth at Risk of Psychosis
This study tests a self-guided digital DBT program to help young people aged 14–35 who are at clinical high risk for psychosis, comparing it to usual care over eight weeks.
-
French version of the Schizophrenia Proneness Instrument for children and adolescents (SPI-CY)
This project will test the French SPI-CY to see if it reliably identifies French-speaking adolescents (ages 12–17) who are at high risk for developing psychosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.